Review: COVID-19 Outbreak and Diabetic Patient’s Treatments Close Relationship

Abstract

The severe acute respiratory syndrome (SARS-COV) are well known viruses from the family of Coronaviridae which in past caused outbreaks that led to various detrimental effect on world in many aspects. In the year 2019 when the new strain of coronavirus family (SARS-COV2) which is now known as COVID-19 (corona virus disease and 19 refer to the year it was first recognized) outbreak occurred in Wuhan affected the globe seriously. The health system got into a big challenge as this new strain of coronavirus spread much rapidly and caused much more mortality than the previous ones. The mortality was higher in those population which had comorbid conditions such as cardiovascular disease, lung disorders, chronic illnesses, diabetic patients and at the same time affected by COVID-19. Various regimes were selected but still proper and effective management is not available for such patients as these patients are already on multiple drugs. Among those chronic illnesses diabetic patients were found be highly susceptible to COVID-19. High disease mortality and worse outcomes in patients with diabetes urges that Diabetes appropriate management and better selection of drugs is crucial for the better outcomes in diabetic patients as most of the patients are treated for hypertension, hyperglycaemia and ongoing other chronic illnesses which could lead to worse case scenarios.